Farmacêutica portuguesa fechou acordo de exclusividade com parceiro da Coreia do Sul que lhe permite garantir o fornecimento de até um milhão de testes rápidos de antigénio de uso profissional por semana nos mercados de Portugal e Espanha.
Up to one million rapid antigen tests for professional use per week. That's the guarantee Biojam offers after closing an "exclusivity partnership" with the South Korean company PCL, which ensures stock to meet demand in Portugal and Spain, and potentially in the PALOP market (Portuguese-Speaking African Countries).
(…) Read the full article in Jornal de Negócios
